PYC Therapeutics Limited's market cap is currently ―. The company's EPS TTM is AU$-0.006; its P/E ratio is -15.83; PYC Therapeutics Limited is scheduled to report earnings on August 27, 2024, and the estimated EPS forecast is AU

gt;-0.01. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 22	Jun 21	Jun 20	Jun 19	Jun 18
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	-	-	-	-	-
EBITDA	-	-	-	-	-
Net Income Common Stockholders	-	-	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	AU$ 29.11M	AU$ 51.50M	AU$ 25.13M	AU$ 6.18M	AU$ 3.15M
Total Assets	AU$ 45.35M	AU$ 57.94M	AU$ 31.55M	AU$ 6.70M	AU$ 3.42M
Total Debt	AU$ 943.77K	AU$ 730.35K	AU$ 798.14K	AU$ 0.00	AU$ 0.00
Net Debt	AU$ -28.17M	AU$ -50.77M	AU$ -24.33M	AU$ -6.18M	AU$ -3.15M
Total Liabilities	AU$ 5.15M	AU$ 4.02M	AU$ 1.35M	AU$ 401.87K	AU$ 1.77M
Stockholders Equity	AU$ 39.35M	AU$ 52.54M	AU$ 27.95M	AU$ 6.30M	AU$ 1.65M
Cash Flow	-
Free Cash Flow	-	-	-	-	-
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in AUD

PYC Therapeutics Limited Earnings and Revenue History

Income Statement >

PYC Therapeutics Limited Debt to Assets

Balance Sheet >

PYC Therapeutics Limited Cash Flow

Cash Flow >

PYC Therapeutics Limited Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing